Top 50 Bioprinting

Precise Bio develops a 4D bio-fabrication platform that utilizes proprietary single-cell resolution bio-printing technology to create scalable, patient-specific tissues and organs from their own cells. This technology addresses the need for personalized regenerative solutions in various medical fields, including cardiology and orthopedics, by providing a reliable method for producing functional biological structures.

TissueLabs provides a platform for 3D bioprinting that includes bioprinters, bioinks, and hydrogels to facilitate the creation of lab-grown tissues and organs. This technology addresses the need for reliable and reproducible models in tissue engineering and regenerative medicine, enhancing research capabilities and accelerating drug discovery.

Brinter develops 3D bioprinted biocomposite implants, known as BioMods™, specifically designed for soft tissue repair, starting with rotator cuff tears. These implants are fully resorbable and engineered to enhance tissue regeneration, addressing the limitations of traditional surgical implants in sports medicine.

Systemic Bio develops vascularized organ models using hydrogels and human cells, enabling more accurate preclinical drug testing. Their proprietary 3D Systems technology offers significantly larger build volumes and higher resolution than existing methods, facilitating the creation of customizable organ-on-chip systems for drug discovery.

This startup manufactures multi-material 3D printing technology that utilizes electrochemistry to fabricate micro and nano-scale electronics, including sensors, photovoltaics, batteries, and PCBs. By enabling in-house production of these devices, the company allows clients to design and develop electronic products without reliance on external manufacturing facilities.

Dimension Inx develops biomaterials that create regenerative microenvironments to enhance cell functionality and restore organ function. Their technology addresses the limitations of traditional cell therapies by providing a three-dimensional matrix that promotes vascular integration and durable therapeutic responses.

The startup develops a high-resolution 3D printer specifically designed for bioprinting live cells using optimized biocompatible materials. This technology enables the production of sterile support structures for tissue regeneration, facilitating the creation of precise microcomponents essential for cell research.

CompagOs develops Bon3OID™ in vitro bone models using 3D bioprinting technology to create biologically relevant human bone tissue for research and drug testing. The company addresses the need for effective therapies in bone health, particularly for rare bone diseases and bone oncology, by providing a platform for drug efficacy and toxicity assessments.

Rapid Liquid Print utilizes patented Gravity Free Manufacturing™ technology to produce stretchable 3D-printed products suspended in a reusable gel, enabling non-planar printing without the need for costly tooling. This approach addresses the limitations of traditional manufacturing by allowing for rapid production of complex designs across various industries, including medical, automotive, and consumer goods.

VoxCell develops bioprinted tissue models using customizable bioinks and advanced vascular structures to provide predictive drug distribution and efficacy data for preclinical trials. This technology addresses the limitations of traditional drug discovery methods by delivering human-like data that enhances the accuracy of therapeutic assessments.

BCN3D Technologies designs and manufactures high-quality 3D printers utilizing Independent Dual Extrusion (IDEX) technology, enabling precise multi-material printing for industrial applications. Their products address the need for efficient and versatile additive manufacturing solutions in sectors such as engineering, healthcare, and product design.

MimiX Biotherapeutics utilizes Sound Induced Morphogenesis to biofabricate artificial human organs and tissues by manipulating sound profiles to pattern biological materials in a contactless environment. This technology addresses the challenge of creating complex, functional tissues for regenerative medicine, enhancing the scalability and accessibility of biofabrication methods.

This startup manufactures industrial-grade stereolithography 3D printers that utilize proprietary lubricant sublayer photo-curing technology and a structured light matrix to achieve high-speed printing. Their solution significantly reduces the time required for producing precision functional parts, enhancing efficiency in the supply chain.

PhosPrint P.C. develops a laser bioprinting system that precisely delivers viable cells and bioinks for tissue regeneration and biosensor applications. This technology provides a novel method for treating bladder cancer, offering a safer alternative to existing treatment options.

Readily3D develops bioprinters that enable rapid and precise fabrication of living tissues and organs. Their technology allows researchers and medical professionals to create complex 3D biological structures for applications in drug discovery, regenerative medicine, and personalized healthcare.

Readily3D develops a tomographic bioprinter that utilizes light-based polymerization to rapidly fabricate centimeter-scale living tissue constructs and solid objects in seconds. This technology enables life scientists to conduct faster design iterations and statistical studies, significantly enhancing the efficiency of biofabrication processes.

Poietis has developed a patented Next Generation Bioprinting (NGB) platform that utilizes Laser-Assisted Bioprinting and bio-extrusion techniques to create complex 3D tissue models with micron-level precision. This technology enables researchers and clinicians to produce viable, implantable tissues, facilitating advancements in regenerative medicine and accelerating the transition from research to clinical applications.

Cellink develops advanced 3D bioprinters and bioinks for the precise fabrication of human tissues, enabling researchers to create patient-specific models for personalized medicine and drug discovery. Their technology addresses the need for more physiologically relevant models in biomedical research, enhancing the understanding of human biology and accelerating therapeutic development.

FluidForm Bio utilizes patented FRESH™ technology to bioprint living human tissue that incorporates cells and vasculature, enabling effective treatments for various diseases. This technology addresses the need for high-quality, functional tissue for applications in tissue restoration, repair, and cell therapy.

This company offers custom 3D bioprinting services and develops specialized bio-inks for research applications. They enable institutions to explore bioprinting for tissue engineering and regenerative medicine without requiring in-house expertise.

Loominus offers a unified platform for 3D biofabrication workflows, combining Loominus Studio software and BioLoom multi-tool 3D printer to enable researchers to design and produce complex biomaterials with high reproducibility. This integrated solution addresses the challenges of workflow complexity and reproducibility in regenerative medicine, accelerating the development and commercialization of advanced medical therapies.

Desktop Health provides high-accuracy 3D printing solutions specifically designed for dental and medical applications, utilizing biocompatible materials and advanced photopolymer technology. The company addresses the need for reliable, regulatory-approved manufacturing processes that enhance personalized patient care and improve clinical outcomes.

The startup develops three-dimensional-printed bone implants using computer-aided design and a calcium phosphate-fatty acid composite that integrates with the body over time. These implants aim to reduce surgical complications and enhance recovery times for patients with tissue and bone damage, while also lowering procedural costs.

Plasmics develops advanced multi-material 3D printing solutions featuring the INo Trident, the world's first commercially available induction heated hotend, which enhances print speed and quality. The startup addresses the lengthy production times of custom medical devices by enabling rapid, precise manufacturing of orthoses and prosthetics within hours instead of weeks.

This startup develops 3D printing technology specifically for the construction industry, enabling the digitization of building processes through advanced manufacturing and automation systems. By facilitating deep personalization, the company enhances productivity and provides customers with a seamless end-to-end construction experience.

3D BioFibR produces collagen fibers using patented dry-spinning technology, enabling the commercial-scale manufacturing of materials that mimic the biomechanical and biochemical properties of natural collagen. These fibers are designed for tissue engineering applications, including 3D bioprinting additives and cellular scaffolds, addressing the need for reliable and scalable biomaterials in regenerative medicine.

BONE 3D specializes in 3D printing of customized anatomical models and medical devices for healthcare professionals, utilizing advanced additive manufacturing techniques to create precise, patient-specific solutions. This technology reduces surgical preparation time and costs by providing accurate models that enhance training and improve surgical outcomes.

The startup manufactures 3D printers and liquid handling systems specifically designed for bioprinting, utilizing proprietary software to optimize cell growth into tissue. By providing consulting services and developing tailored material formulas, the company enhances efficiency in the healthcare sector, addressing the need for more effective tissue engineering solutions.

Provides xeno-free bioinks and 3D tissue models compatible with multiple bioprinting platforms, enabling high cell viability and reduced labor costs in tissue engineering. These turn-key reagents and consulting services support researchers in developing functional human tissues for applications such as drug testing, toxicity screening, and regenerative medicine.

Phase utilizes a proprietary platform to 3D print microfluidic devices using biocompatible materials like PDMS at high resolution and commercial scale. This technology enables the rapid production of integrated components such as valves and sensors, facilitating advancements in biomedical research and the development of new treatments.

This startup manufactures high-performance components for three-dimensional printers, including extruders, hot ends, nozzles, and sensors, which enhance the precision of material deposition. By providing these critical parts and a diverse range of printing services, the company improves the reliability and functionality of 3D printing in various industrial applications.

The startup develops orthopedic casts using 3D printing technology to create lightweight, waterproof, and breathable products that are custom-fitted for each patient. This approach enhances patient comfort and allows medical professionals to efficiently apply, remove, and monitor the healing process for fractures.

Alvox Bio provides 3D bioprinting services to create customized tissue models for drug discovery and personalized medicine, utilizing advanced bio-materials and high-throughput in vitro techniques. This technology enables researchers and pharmaceutical companies to evaluate safety, toxicity, and therapeutic potential more accurately, accelerating the development of new therapies.

The startup provides 3D printing and prototyping services to automate construction processes, significantly lowering production costs and carbon emissions. By utilizing additive manufacturing techniques, the company addresses inefficiencies in traditional construction methods.

Carcinotech manufactures 3D printed living tumors that accurately replicate human tumor biology, providing researchers with precise models for cancer studies. This technology enhances drug testing efficacy and supports the development of personalized treatment strategies, overcoming the limitations of conventional cancer research methods.

This company manufactures hydrogel bioinks that mimic extracellular matrices, enabling cells to grow and proliferate in realistic 3D environments for 3D cell culture and bioprinting. Their bioinks replicate the properties of specific tissues to support cell growth.

The startup develops customized bone models using 3D-printed biocompatible surgical guides and titanium alloy implants to create patient-specific surgical solutions. This technology reduces surgery time, lowers malpractice rates, and shortens patient recovery periods.

Tessella Biosciences develops ready-to-use bioinks and biopolymers designed for 3D bioprinting, featuring high printability and tunable mechanical properties for accurate tissue modeling. Their products enhance cell viability and enable the printing of complex structures, addressing the challenges of reproducibility and performance in bioprinting applications.

This startup provides three-dimensional construction printing technology designed for mainstream construction applications. Their platform enables builders to reduce costs, accelerate build times, and enhance structural integrity while allowing for greater design flexibility.

This startup manufactures prosthetic limbs using three-dimensional printing technology, offering a customizable and interchangeable prosthetics system that allows for in-person measurement. Their design addresses mobility issues faced by amputee patients by providing personalized solutions that enhance functionality and comfort.

This startup manufactures metal surgical tools, anatomical models, and biocompatible materials while providing services such as computer-aided design, 3D printing, and fast prototyping. By offering tailored surgical instruments and training resources, the company enhances surgeons' skills and improves surgical outcomes.

The startup develops bio-printed three-dimensional human bone tissue using pneumatic extrusion technology, creating a native-like micro-architecture for in-vitro efficacy and toxicity assays. This technology enables pharmaceutical companies to conduct drug testing with artificial human tissues, bridging the gap between pre-clinical and clinical phases of drug development.

3D Orthobiologic Solutions is creating customizable, 3D-printed scaffolds for bone repair and regeneration, utilizing precise additive manufacturing techniques. This technology provides tailored structural support that enhances healing and integration with existing bone tissue, overcoming the limitations of traditional grafting methods.

Cell Drive develops a patented modular bioink platform that enables the on-demand production of living tissues through 3D bioprinting, utilizing synthetic bioinks that promote cell adhesion without crosslinkers or photoinitiators. This technology addresses the need for biocompatible and biodegradable materials in tissue engineering and regenerative medicine, facilitating the creation of in vitro tissue models and drug delivery systems.

Copner Biotech offers a Renderable Biofabrication platform for precise additive manufacturing of complex biological models. Their GRAPE® data format and extrusion bioprinters enable the creation of advanced 3D cell culture scaffolds with controlled gradients, improving cell growth and viability for research applications.

This startup develops 3D printing technology specifically for aluminum manufacturing, enabling the rapid and precise production of complex aluminum components. By providing a cost-effective and sustainable alternative to traditional manufacturing methods, the company supports industries such as aerospace, automotive, and medical devices in overcoming limitations associated with conventional processes.

Vital3D Technologies utilizes Two-Photon Polymerization and FemtoBrush technology to produce high-resolution, bioprinted tissues and organs with complex vascular systems for medical research and regenerative medicine. The company addresses the need for functional, implantable 3D bioprinted organs by developing scalable solutions that enhance precision and speed in bioprinting processes.

The startup develops biomaterials for tissue repair and 3D printing medical devices, providing alternatives to silicone and fillers in reconstructive procedures. Their technology includes advanced molding implants and alternative evaluation models for animal testing, enhancing the efficacy and safety of tissue restoration.

This startup develops artificial intelligence-powered 3D printing software that digitizes project management in a cloud environment, enabling efficient design, simulation, and development of customized models and prototypes. By offering integrated services alongside a range of third-party 3D printers and materials, the company facilitates the rapid realization of client ideas in the 3D printing space.

The startup develops multiport 3D-printed microcapillary needles to enhance precision in microinjection procedures. This technology improves the accuracy and efficiency of biomedical research and disease prevention modeling, enabling healthcare professionals to deliver therapies more effectively.